BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16945162)

  • 21. Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder.
    Bartzokis G; Lu PH; Turner J; Mintz J; Saunders CS
    Biol Psychiatry; 2005 Mar; 57(5):474-9. PubMed ID: 15737661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder.
    Villarreal G; Hamner MB; Qualls C; Cañive JM
    Psychopharmacol Bull; 2018 Feb; 48(2):8-17. PubMed ID: 29713096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baclofen treatment for chronic posttraumatic stress disorder.
    Drake RG; Davis LL; Cates ME; Jewell ME; Ambrose SM; Lowe JS
    Ann Pharmacother; 2003 Sep; 37(9):1177-81. PubMed ID: 12921495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of atypical antipsychotic medications for posttraumatic stress disorder.
    Ahearn EP; Juergens T; Cordes T; Becker T; Krahn D
    Int Clin Psychopharmacol; 2011 Jul; 26(4):193-200. PubMed ID: 21597381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis.
    Sajatovic M; Mullen JA; Sweitzer DE
    J Clin Psychiatry; 2002 Dec; 63(12):1156-63. PubMed ID: 12523876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone.
    Mintzer JE; Mullen JA; Sweitzer DE
    Curr Med Res Opin; 2004 Sep; 20(9):1483-91. PubMed ID: 15383198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants.
    Youssef NA; Marx CE; Bradford DW; Zinn S; Hertzberg MA; Kilts JD; Naylor JC; Butterfield MI; Strauss JL
    Int Clin Psychopharmacol; 2012 Jul; 27(4):191-6. PubMed ID: 22475888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504.
    Krystal JH; Pietrzak RH; Rosenheck RA; Cramer JA; Vessicchio J; Jones KM; Huang GD; Vertrees JE; Collins J; Krystal AD;
    J Clin Psychiatry; 2016 Apr; 77(4):483-91. PubMed ID: 26890894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine compared to quetiapine in adolescents with a first psychotic episode.
    Arango C; Robles O; Parellada M; Fraguas D; Ruiz-Sancho A; Medina O; Zabala A; Bombín I; Moreno D
    Eur Child Adolesc Psychiatry; 2009 Jul; 18(7):418-28. PubMed ID: 19198920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study.
    Ahearn EP; Mussey M; Johnson C; Krohn A; Krahn D
    Int Clin Psychopharmacol; 2006 Jan; 21(1):29-33. PubMed ID: 16317314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ziprasidone therapy for post-traumatic stress disorder.
    Siddiqui Z; Marcil WA; Bhatia SC; Ramaswamy S; Petty F
    J Psychiatry Neurosci; 2005 Nov; 30(6):430-1. PubMed ID: 16327877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet serotonin in combat related posttraumatic stress disorder with psychotic symptoms.
    Pivac N; Kozaric-Kovacic D; Mustapic M; Dezeljin M; Borovecki A; Grubisic-Ilic M; Muck-Seler D
    J Affect Disord; 2006 Jul; 93(1-3):223-7. PubMed ID: 16647142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine treatment for post-traumatic stress disorder: an open-label study.
    Petty F; Brannan S; Casada J; Davis LL; Gajewski V; Kramer GL; Stone RC; Teten AL; Worchel J; Young KA
    Int Clin Psychopharmacol; 2001 Nov; 16(6):331-7. PubMed ID: 11712621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term use of quetiapine in elderly patients with psychotic disorders.
    Tariot PN; Salzman C; Yeung PP; Pultz J; Rak IW
    Clin Ther; 2000 Sep; 22(9):1068-84. PubMed ID: 11048905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open-label assessment of aripiprazole in the treatment of PTSD.
    Robert S; Hamner MB; Durkalski VL; Brown MW; Ulmer HG
    Psychopharmacol Bull; 2009; 42(1):69-80. PubMed ID: 19204652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
    Honer WG; MacEwan GW; Gendron A; Stip E; Labelle A; Williams R; Eriksson H;
    J Clin Psychiatry; 2012 Jan; 73(1):13-20. PubMed ID: 21733490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder.
    Hamner MB; Frueh BC; Ulmer HG; Arana GW
    Biol Psychiatry; 1999 Apr; 45(7):846-52. PubMed ID: 10202572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
    György B; Robert K; László C; Andrea J;
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of quetiapine vs haloperidol and placebo: a meta-analytic study of efficacy.
    Schulz SC; Thomson R; Brecher M
    Schizophr Res; 2003 Jul; 62(1-2):1-12. PubMed ID: 12765737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.